Final Incomplete Exam 711 - MA
Final Incomplete Exam 711 - MA
Faculty of Pharmacy
N.B. The oral exam will be directly after the written exam at room J110 in
Building J.
Q-I) Choose the correct answer and put it in the provided answer sheet [95
Marks].
N.B. Only answers in the answer sheet will be considered, therefore, put your
answer in the provided answer sheet.
1- The active metabolite of Diltiazem
1
3- From structure activity relationship of 1,4-Dihydropyridines:
1- 1,4-Dihydropyridine ring (DHP) with secondary cyclic amine are essential.
2- Positions 3 and 5 are carboxylic groups that must be protected with an ester functional
group.
3- Position 4 requires an aromatic substitution possessing an electron-donating group in
the ortho and/or meta position.
4- Positions 2 and 6 small alkyl group, that may play a role in the duration of action.
a) All of them b) All except 3 c) All except 1 d) 1 &2
a) b) c)
7- The active metabolite of Propranolol is
a) 4-Hydroxypropranolol.
b) Naphthoxylactic acid.
c) N-dealkylated derivative.
d) None of them.
2
9- From SAR of Beta blockers,
1- Most of β-blockers are in the chemical class of aryloxypropanolamines
2- For maximal β –blockers: the β -OH-substituted carbon must be in the R absolute
3- The aromatic ring can either be benzoheterocyclic (such as indole) or heterocyclic (such as
thiadiazole).
4- The X part of the side chain can either be CH2CH2—, —CH=CH—, —SCH2— or —NCH2
5- Branched R1 group is the optimal for activity
6- Alkyl (—CH3) substituents on the α, β or γ carbon (if X = —OCH2—) enhances beta
blockade, especially at the α carbon
a) 1 &4 & 5 b) 1 &3 & 6 c) 2 &3 & 5 d) 1 &3 & 5
17- Which of the following is selective α1 antagonist selectively bind to receptors in the
prostate aiding to the treatment of BPH?
a) Prazosin. b) Tamsulosin. c) Salbutamol. d) Mirabegron.
18- Salbutamol is an important clinical agent. What role does the t-butyl group play?
a) It acts as steric shield to reduce metabolism.
b) It increases hydrophobicity such that the molecule can cross cell membranes.
c) It introduces selectivity for β-adrenoceptors.
d) It introduces selectivity for α-adrenoceptors.
c) 3-Phenyl-3-(4-trifluoromethylphenoxy)-N-methylpropylamine
d) 3-Phenoxy-3-(4-trifluoroethylphenyl)-N-ethylpropylamine N
H3C H
4
23- Which of the following is true for MAOIs
a) They can lead to hypotensive reactions.
b) They can decrease the degradation of dietary tyramine.
c) They reversibly inhibit monoamines reuptake.
d) They irreversibly inhibit monoamines reuptake.
24- o-Quinonoid is a reactive metabolite of ……………
a) Fluoxetine. b) Trazodone. c) Paroxetine. d) Atomoxetine.
5
c) C > B > A. d) C > A > B.
30- The following structures can be arranged according to their potency as skeletal
muscle relaxants:
31- Pregabalin:
a) Increases the expression of glutamic acid decarboxylase
which is responsible for GABA synthesis.
b) Its S- isomer is an active enantiomer.
c) Blocks presynaptic voltage-gated Ca2+ channels.
d) All the above.
33- The following inhalation anesthetics can be arranged according to their potency:
6
34- Levodopa should be taken with carbidopa in Parkinson`s disease because:
a) Carbidopa is a peripheral DOPA decarboxylase inhibitor.
b) Carbidopa ensures high delivery of L-DOPA to CNS.
c) Carpidopa decreases amount of formed Dopamine peripherally decreasing its side
effects.
d) All of the above.
7
(a) (b) (c) (d)
Compound A Compound B
a) Compound A is more potent and causes less sedation than compound B.
b) Compound A is less potent and causes more sedation than compound B.
c) Compound A is more potent and causes more sedation than compound B.
d) Compound A is less potent and causes less sedation than compound B.
8
46- The active form of pantoprazole is
a) b) c) d)
49- Which of the following regions is not involved in local anesthetics receptor
interaction?
a) Region A. b) Region B.
c) Region C. d) Region D.
a) b)
9
c) d)
c)
d) a & c
53- Glibizide has longer duration of action than tolazamide due to presence of
............ moiety
a) Sulfonylurea.
b) Cyclohexyl.
c) substituted arylcaboxyamidoethyl.
d) All of the above.
10
56- ........................................in saxagliptin form a covalent
bond with serine 630 OH in the enzyme catalytic residue of
DPP-4 enzyme.
a) Adamantyl group. b) CN group.
c) Amide group. d) Amide and CN groups.
a) b)
c) d) None of them.
62- The drug shown in the figure has no CNS opioid effects
due to
a) it does not cross BBB.
b) its polarity.
c) its lipophilicity.
d) none of these.
11
63- The illustrated drug has the following action
a) Antiemetic.
b) Antidiarrheal.
c) Antiulcer.
d) None of them.
64- All of the following are correct about this drug except:
a) it is an antiplatelet agent.
b) it is a phosphodiesterase inhibitor.
c) it decreases the intraplatelet cAMP.
d) it is used in combination with aspirin.
68- In the following cardiotonic agent, presence of the encircled moiety making
it.………..
a) β1-adrenergic receptor agonist.
b) phosphodiesterase III activator.
c) phosphodiesterase III inhibitor.
d) β1-adrenergic receptor antagonist.
12
71- ……….. …..…………… resulted in scurvy
a) Deficiency of vitamin B6. b) Hypervitaminosis of vitamin A.
c) Hypervitaminosis of vitamin K. d) Deficiency of vitamin C.
13
B- Draw 2 metabolites of Diazepam, one is active and the other one is inactive: (2
marks)
End of questions
Good luck
Prof. Dr. Ramzia ElBagary
Prof. Dr. Doaa Ezzat
Prof. Dr. Riham F. George
Dr. Samar Hashem
Dr. Mona Fikry
Dr. Ghada Elmasry
Dr. Menna-Allah Mohamed
Dr. Noha Mohamed
14